Back
Kymera Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
68
KYMR
Kymera Therapeutics, Inc.
Last Price:
$90.10
Seasonality Move:
-21.77%
7 Day Trial
ALL ACCESS PASS
$
7
Kymera Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Kymera Therapeutics, Inc. has on average historically risen by 30% based on the past 5 years of stock performance.
-
Kymera Therapeutics, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Kymera Therapeutics, Inc. Stock Undervalued?The current Kymera Therapeutics, Inc. [KYMR] share price is $91.35. The Score for KYMR is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Kymera Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Kymera Therapeutics, Inc. has on average historically risen by 30% based on the past 5 years of stock performance.
Kymera Therapeutics, Inc. Stock Rating
Buy
68
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. overpriced?
-
Kymera Therapeutics, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Kymera Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kymeratx.com
52-Week Data
52-Week High:
103.00
52-Week Low:
19.45
Prediction Charts
Market Cap:
6.6B
Price in USD:
91.35
Volume:
1.2M
Beta:
2.14
Technical Analysis
SMA50:
78.86
SMA100:
71.98
SMA200:
57.83
52-Wk Change:
201.98%
Stock Predictions
-
Is Kymera Therapeutics, Inc. stock public?Yes, Kymera Therapeutics, Inc. is a publicly traded company.
-
What is the Kymera Therapeutics, Inc. stock quote today?The Kymera Therapeutics, Inc. stock price is 91.35 USD today.
-
How to buy Kymera Therapeutics, Inc. stock online?You can buy Kymera Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-9 | 79.24 | 79.02 | 80.58 | 76.78 |
| Feb-10 | 78.75 | 79.49 | 80.95 | 78.14 |
| Feb-11 | 78.98 | 82.27 | 82.47 | 76.52 |
| Feb-12 | 82.78 | 84.02 | 86.00 | 81.83 |
| Feb-13 | 84.64 | 82.34 | 86.18 | 82.05 |
| Feb-17 | 82.06 | 84.84 | 85.44 | 80.36 |
| Feb-18 | 84.23 | 85.11 | 88.40 | 83.61 |
| Feb-19 | 84.54 | 86.50 | 86.54 | 82.48 |
| Feb-20 | 86.06 | 87.40 | 89.28 | 85.60 |
| Feb-23 | 87.16 | 88.43 | 89.49 | 85.70 |
| Feb-24 | 88.59 | 91.01 | 91.99 | 87.37 |
| Feb-25 | 91.40 | 90.68 | 93.64 | 89.06 |
| Feb-26 | 86.00 | 95.03 | 95.90 | 83.74 |
| Feb-27 | 92.14 | 91.35 | 93.99 | 88.80 |
Kymera Therapeutics, Inc. Earnings
Kymera Therapeutics, Inc. Earnings Report: Per Share Kymera Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Kymera Therapeutics, Inc. Forecast Revenue Growth
Kymera Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Kymera Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, an increase next quarter of $0.16 per share, a decrease this year of $0.21 per share, and a decrease next year of $0.46 per share.
* Kymera Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.